BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7335479)

  • 1. [Effect of radiotherapy on the immunocompetence in patients with bronchogenic carcinoma and laryngeal cancer (author's transl)].
    Oshitani T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(9):873-86. PubMed ID: 7335479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological examination of patients with bronchogenic carcinoma (author's transl)].
    Foltýnová V; Mostecký H; Dienstbier Z; Hlavatý V; Koprivová H; Rezný Z
    Sb Lek; 1980 Mar; 82(3):89-96. PubMed ID: 7367805
    [No Abstract]   [Full Text] [Related]  

  • 3. [The immunostate and immunotherapy of primary bronchogenic carcinoma (author's transl)].
    Deng WW
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(1):56-8. PubMed ID: 551912
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological studies and immunotherapeutic possibilities in inoperable bronchogenic carcinoma (author's transl)].
    Titscher R; Micksche M
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():371-2. PubMed ID: 461311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multitest evaluation of the immune status of patients with bronchogenic carcinoma before and after radiotherapy].
    Gava A; Fontan L; Marazzato G; De Angeli S
    Minerva Med; 1990 Mar; 81(3):135-8. PubMed ID: 2320281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological diagnosis of bronchogenic carcinoma (author's transl)].
    Schlipköter HW; Idel H; Stiller-Winkler R
    Prax Klin Pneumol; 1982 Apr; 36(4):198-201. PubMed ID: 7048283
    [No Abstract]   [Full Text] [Related]  

  • 7. [5 years survival after radiotherapy for lung cancer (author's transl)].
    Kujawska J; Strzeszyński J
    Przegl Lek; 1973 Dec; 30(12):912-6. PubMed ID: 4783585
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical relevancy of cellular immunity in bronchogenic carcinoma].
    Muhrer KH; Filler D; Schwemmle K; Gierhake FW
    Prax Klin Pneumol; 1982 Aug; 36(8):335-9. PubMed ID: 7134160
    [No Abstract]   [Full Text] [Related]  

  • 9. [The changes in antibody dependent cell-mediated cytotoxicity (ADCC) in cancer patients during radiotherapy--estimation by plaque assay].
    Ichiyanagi A
    Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1032-40. PubMed ID: 6389731
    [No Abstract]   [Full Text] [Related]  

  • 10. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE; DeVald B
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibodies against tumor associated antigens of human bronchogenic carcinoma: demonstration by anti-complement immunofluorescence (author's transl)].
    Schlipköter HW; Stiller-Winkler R; Idel H; Knopp J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 174(1-2):105-14. PubMed ID: 7034407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic studies in bronchogenic carcinoma.
    Zeromski J
    Ann Med Sect Pol Acad Sci; 1974; 19(3-4):197-236. PubMed ID: 4616524
    [No Abstract]   [Full Text] [Related]  

  • 13. Demonstration of immune reactions against cultured hamartoma cells with lymphocytes from patients with bronchogenic carcinoma.
    Pierce GE; Allingham R; Bell JW
    Surg Forum; 1972; 23(0):89-91. PubMed ID: 4671035
    [No Abstract]   [Full Text] [Related]  

  • 14. [The bronchogenic carcinoma-laryngeal cancer association: the experience of our school].
    Mascitelli E; Cipollone G; Sabetti G; Quitadamo S; Gidaro GS
    G Chir; 1997 Oct; 18(10):619-21. PubMed ID: 9479975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro assays of immunocompetence in bronchogenic carcinoma.
    Alsabti EA
    Oncology; 1979; 36(4):171-5. PubMed ID: 157453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinoembryonic antigen (CEA) in the blood serum of patients with bronchogenic carcinoma and selected diseases of the respiratory tract].
    Szklarz E; Gawlikowski W
    Pneumonol Pol; 1989 Apr; 57(4):217-21. PubMed ID: 2628950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immunoglobulin levels in cancer patients. I. Serum immunoglobulins and primary tumor localization.
    Dostálová O; Schön E; Wagnerová M; Jelínek J; Wagner V
    Neoplasma; 1975; 22(5):539-46. PubMed ID: 1196438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The evaluation of surgical therapy for bronchogenic carcinoma in the patients over 70 years old (author's transl)].
    Yasumitsu T; Kotake Y; Takao T; Ito Y; Nakamura K; Nagaoka Y; Sawamura K; Nakaoka K; Maeda M; Kawashima Y; Masaoka A
    Kyobu Geka; 1981 Jun; 34(6):421-5. PubMed ID: 7265583
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoembryonic antigen in bronchogenic carcinoma.
    Zatloukal P; Voslárová Z; Mĕricka O; Svarcová H; Schützner J
    Neoplasma; 1987; 34(1):73-6. PubMed ID: 3561607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.